Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Half-dose Ticagrelor vs Clopidogrel in Unruptured Intracranial Aneurysms
NCT06486363Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Aug 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of ticagrelor in brain aneurysm (IA) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Incidence rate of cerebral stroke at 6 months, Modified Rankin Scale at 6 months and 1 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
ticagrelor
03
Conditions
brain aneurysm (IA)
Beyond the preview
Go deeper on NCT06486363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06486363.